Literature DB >> 34655477

Impact of human papillomavirus on the tumor microenvironment in oropharyngeal squamous cell carcinoma.

Xinyi Liu1,2, Ping Liu3, Rebecca D Chernock4, Krystle A Lang Kuhs5, James S Lewis6,7, Hua Li8,9,10, Hiram A Gay3, Wade L Thorstad3, Xiaowei Wang1,2.   

Abstract

Increasing evidence has elucidated the clinicopathological significance of tumor microenvironment (TME) cells. However, TME differences associated with human papillomavirus (HPV) infection in oropharyngeal squamous cell carcinoma (OPSCC) have not been well characterized. In our study, we comprehensively determined the TME infiltration patterns in 315 OPSCC patients, and systematically correlated the TME phenotypes with genomic characteristics and clinical features of OPSCCs. In this way, we observed the enrichment of high endothelial cells and adaptive immune cells in HPV-positive (HPV+) OPSCCs, in contrast to the enrichment of fibroblasts and capillary endothelial cells in HPV- negative (HPV-) OPSCCs. By focusing on immune checkpoint genes, we constructed a coexpression network using genes that were differentially expressed between HPV+ and HPV- OPSCCs. Functional analysis of the network indicated that HPV+ OPSCCs had elevated immune activities by promoting adaptive immune response and suppressing activities related to extracellular matrix organization. Subsequently, clinical analysis showed that identified TME-relevant genes were closely associated with the prognosis and therapy response in OPSCC. Importantly, results from the TME analysis were further validated using an independent OPSCC cohort.
© 2021 UICC.

Entities:  

Keywords:  RNA-seq; human papillomavirus; oropharyngeal cancer; tumor microenvironment

Mesh:

Substances:

Year:  2021        PMID: 34655477      PMCID: PMC8665085          DOI: 10.1002/ijc.33849

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  44 in total

Review 1.  Metabolism shapes the tumor microenvironment.

Authors:  Miguel Reina-Campos; Jorge Moscat; Maria Diaz-Meco
Journal:  Curr Opin Cell Biol       Date:  2017-06-09       Impact factor: 8.382

2.  CD10+GPR77+ Cancer-Associated Fibroblasts Promote Cancer Formation and Chemoresistance by Sustaining Cancer Stemness.

Authors:  Shicheng Su; Jianing Chen; Herui Yao; Jiang Liu; Shubin Yu; Liyan Lao; Minghui Wang; Manli Luo; Yue Xing; Fei Chen; Di Huang; Jinghua Zhao; Linbin Yang; Dan Liao; Fengxi Su; Mengfeng Li; Qiang Liu; Erwei Song
Journal:  Cell       Date:  2018-01-25       Impact factor: 41.582

3.  Role of cell-cell communication in inhibiting butyric acid-induced T-cell apoptosis.

Authors:  Tomoko Kurita-Ochiai; Shintaro Seto; Kuniyasu Ochiai
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

4.  A draft network of ligand-receptor-mediated multicellular signalling in human.

Authors:  Jordan A Ramilowski; Tatyana Goldberg; Jayson Harshbarger; Edda Kloppmann; Edda Kloppman; Marina Lizio; Venkata P Satagopam; Masayoshi Itoh; Hideya Kawaji; Piero Carninci; Burkhard Rost; Alistair R R Forrest
Journal:  Nat Commun       Date:  2015-07-22       Impact factor: 14.919

5.  The Papillomavirus Episteme: a major update to the papillomavirus sequence database.

Authors:  Koenraad Van Doorslaer; Zhiwen Li; Sandhya Xirasagar; Piet Maes; David Kaminsky; David Liou; Qiang Sun; Ramandeep Kaur; Yentram Huyen; Alison A McBride
Journal:  Nucleic Acids Res       Date:  2016-10-05       Impact factor: 16.971

6.  Simulated Microgravity Condition Alters the Gene Expression of some ECM and Adhesion Molecules in Adipose Derived Stem Cells.

Authors:  Farid Ebnerasuly; Zahra Hajebrahimi; Seyed Mehdi Tabaie; Mojtaba Darbouy
Journal:  Int J Mol Cell Med       Date:  2018-10-08

7.  Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1.

Authors:  David A Barbie; Pablo Tamayo; Jesse S Boehm; So Young Kim; Susan E Moody; Ian F Dunn; Anna C Schinzel; Peter Sandy; Etienne Meylan; Claudia Scholl; Stefan Fröhling; Edmond M Chan; Martin L Sos; Kathrin Michel; Craig Mermel; Serena J Silver; Barbara A Weir; Jan H Reiling; Qing Sheng; Piyush B Gupta; Raymond C Wadlow; Hanh Le; Sebastian Hoersch; Ben S Wittner; Sridhar Ramaswamy; David M Livingston; David M Sabatini; Matthew Meyerson; Roman K Thomas; Eric S Lander; Jill P Mesirov; David E Root; D Gary Gilliland; Tyler Jacks; William C Hahn
Journal:  Nature       Date:  2009-10-21       Impact factor: 49.962

8.  Transcriptional programs of lymphoid tissue capillary and high endothelium reveal control mechanisms for lymphocyte homing.

Authors:  Mike Lee; Helena Kiefel; Melissa D LaJevic; Matthew S Macauley; Hiroto Kawashima; Edward O'Hara; Junliang Pan; James C Paulson; Eugene C Butcher
Journal:  Nat Immunol       Date:  2014-08-31       Impact factor: 25.606

9.  Reference sequence (RefSeq) database at NCBI: current status, taxonomic expansion, and functional annotation.

Authors:  Nuala A O'Leary; Mathew W Wright; J Rodney Brister; Stacy Ciufo; Diana Haddad; Rich McVeigh; Bhanu Rajput; Barbara Robbertse; Brian Smith-White; Danso Ako-Adjei; Alexander Astashyn; Azat Badretdin; Yiming Bao; Olga Blinkova; Vyacheslav Brover; Vyacheslav Chetvernin; Jinna Choi; Eric Cox; Olga Ermolaeva; Catherine M Farrell; Tamara Goldfarb; Tripti Gupta; Daniel Haft; Eneida Hatcher; Wratko Hlavina; Vinita S Joardar; Vamsi K Kodali; Wenjun Li; Donna Maglott; Patrick Masterson; Kelly M McGarvey; Michael R Murphy; Kathleen O'Neill; Shashikant Pujar; Sanjida H Rangwala; Daniel Rausch; Lillian D Riddick; Conrad Schoch; Andrei Shkeda; Susan S Storz; Hanzhen Sun; Francoise Thibaud-Nissen; Igor Tolstoy; Raymond E Tully; Anjana R Vatsan; Craig Wallin; David Webb; Wendy Wu; Melissa J Landrum; Avi Kimchi; Tatiana Tatusova; Michael DiCuccio; Paul Kitts; Terence D Murphy; Kim D Pruitt
Journal:  Nucleic Acids Res       Date:  2015-11-08       Impact factor: 16.971

Review 10.  Immune Checkpoint Modulators: An Emerging Antiglioma Armamentarium.

Authors:  Eileen S Kim; Jennifer E Kim; Mira A Patel; Antonella Mangraviti; Jacob Ruzevick; Michael Lim
Journal:  J Immunol Res       Date:  2016-01-04       Impact factor: 4.818

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.